stars 1 stars 2 stars 3

Every day human tissues are thrown away after surgery. At CTIBIOTECH we save them and give them new purpose, To advance human therapies, to develop new medicines, to test cosmetics or test anything that comes into contact with us. For a better human world. Founded in 2009, we have laboratories in Lyon, France and Philadelphia, USA. We have 4 wings to our company: CTIBIOSOURCING - providing human tissues, cells and culture media globally. CTISKIN - the world's most advanced manual and 3D Bioprinted human skin models for drug, device and cosmetics testing. CTIPHARMA - sophisticated human tissue models for vaccine and pharmaceuticals testing. CTITHERAPY - developing human tissues and diagnostics for work in hospitals. CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors, other) to develop models and bioassays needed to test the efficiency and effect of anything that can affect a human. Our models have varying levels of complexity suited our clients needs in the pharmaceutical industry and dermato-cosmetics sectors. We also work in partnership to co-develop new models that fit a specific requirement. The CTIBIOTECH Biobank is accredited and we can offer human tissues, primary cells, cell lines and tumours. We currently store around many thousands of samples, from 0-94 years and from different ethnical backgrounds. Our customers and partners come from all over the world,

CTIBiotech Questions

Colin McGuckin is the Director and Founder of CTIBiotech.

19 people are employed at CTIBiotech.

Top CTIBiotech Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users